This opthalmology journal could be an updated glaucoma management therapy for its publication in Desember 2007. In the previous article, we have discussed about osmotic therapy for glaucoma, in this article we can find a brief overview of the evolving definition of glaucoma and continues with a review of methods of classifying glaucoma, and their implications for treatment of the disease.

Glaucoma is a painful disease that causes progressive loss of vision and frequently leads to blindness. Medical treatment of glaucoma remains a therapeutic challenge because of the numerous causes of the disease and the complexity of its pathogenesis, accordingly.

In the section of goal therapy, both preserving vision and relieving pain are two primary goals of glaucoma therapy. Principles of treatment, and the various classes of available drugs such Carbonic anhydrase inhibitors, Beta blockers, Adrenergic agonists, Parasympathomimetic (cholinergic) agents, Prostaglandin analogues are well described.

This journal of opthalmology concluded with a discussion of recent advances in the understanding of the pathogenesis of glaucomatous loss of vision, and their therapeutic implications in the development of neuroprotective treatments for glaucoma. Find complete read about Glaucoma Therapy Management, an Updated Journal here.